Focus Financial Network’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,034
Closed -$204K 767
2026
Q1
$204K Sell
1,034
-1,556
-60% -$300K 0.01% 704
2025
Q4
$476K Sell
2,590
-461
-15% -$80.9K 0.02% 457
2025
Q3
$468K Sell
3,051
-198
-6% -$30K 0.02% 460
2025
Q2
$454K Sell
3,249
-82
-2% -$11.5K 0.02% 457
2025
Q1
$490K Buy
3,331
+146
+5% +$21.1K 0.02% 423
2024
Q4
$417K Buy
3,185
+537
+20% +$75.2K 0.02% 460
2024
Q3
$413K Buy
2,648
+221
+9% +$35.7K 0.02% 457
2024
Q2
$387K Buy
2,427
+14
+0.6% +$2.11K 0.02% 462
2024
Q1
$330K Buy
+2,413
New +$320K 0.02% 472
2023
Q4
Sell
-2,437
Closed -$330K 714
2023
Q3
$330K Sell
2,437
-218
-8% -$29.8K 0.02% 440
2023
Q2
$380K Hold
2,655
0.02% 416
2023
Q1
$369K Buy
2,655
+359
+16% +$48.3K 0.02% 402
2022
Q4
$311K Sell
2,296
-71
-3% -$8.9K 0.03% 364
2022
Q3
$260K Sell
2,367
-176
-7% -$22.3K 0.02% 394
2022
Q2
$336K Hold
2,543
0.03% 363
2022
Q1
$337K Sell
2,543
-2,154
-46% -$258K 0.02% 372
2021
Q4
$547K Sell
4,697
-1,634
-26% -$192K 0.08% 208
2021
Q3
$760K Buy
6,331
+796
+14% +$92.7K 0.1% 182
2021
Q2
$663K Buy
5,535
+436
+9% +$47.8K 0.09% 213
2021
Q1
$507K Buy
+5,099
New +$513K 0.06% 251

Other funds holding AZN

Focus Financial Network's AZN Position: Q2 2026 in Review

Focus Financial Network sold out of AstraZeneca (AZN) in Q2 2026, closing a stake of 1,034 shares — an estimated $204K sold.

Focus Financial Network first reported a position in AZN in Q1 2021 and held it in 20 quarters. The position peaked at $760K in Q3 2021. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Focus Financial Network reported no remaining AstraZeneca position as of Q2 2026 after selling out during the quarter.
  • Focus Financial Network sold 1,034 AstraZeneca shares in Q2 2026, an estimated $204K.
  • Focus Financial Network first reported a position in AstraZeneca in Q1 2021 and held it in 20 quarters.
  • Focus Financial Network's AstraZeneca position peaked at $760K in Q3 2021.
  • 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Focus Financial Network's 13F filing for Q2 2026, filed 9 Jul 2026.